XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Feb. 28, 2023
Feb. 28, 2022
Feb. 28, 2021
Cash provided by operating activities:      
Net income $ 143,273,000 $ 223,764,000 $ 253,946,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 44,683,000 35,829,000 37,718,000
Amortization of financing costs 1,114,000 986,000 1,021,000
Non-cash operating lease expense 9,702,000 9,580,000 6,895,000
Provision for credit losses 1,798,000 312,000 2,093,000
Non-cash share-based compensation 26,753,000 34,618,000 26,418,000
Asset impairment charges 0 0 8,452,000
Gain on sale of Personal Care business (1,336,000) (513,000) 0
Loss (gain) on the sale or disposal of property and equipment 63,000 (2,243,000) 193,000
Deferred income taxes and tax credits (2,242,000) (8,871,000) (4,400,000)
Changes in operating capital, net of effects of acquisition of businesses:      
Receivables 83,624,000 (66,834,000) (38,149,000)
Inventory 110,304,000 (45,913,000) (220,817,000)
Prepaid expenses and other current assets 2,778,000 (5,589,000) (2,033,000)
Other assets and liabilities, net (355,000) (6,595,000) (6,613,000)
Accounts payable (115,931,000) (43,745,000) 175,784,000
Accrued expenses and other current liabilities (88,040,000) (3,593,000) 73,010,000
Accrued income taxes (7,946,000) 19,630,000 588,000
Net cash provided by operating activities 208,242,000 140,823,000 314,106,000
Cash used by investing activities:      
Capital and intangible asset expenditures (174,864,000) (78,039,000) (98,668,000)
Net payments to acquire businesses, net of cash acquired (146,342,000) (410,880,000) 0
Proceeds from sale of Personal Care business 1,804,000 44,700,000 0
Proceeds from the sale of property and equipment 69,000 5,305,000 0
Net cash used by investing activities (319,333,000) (438,914,000) (98,668,000)
Cash provided (used) by financing activities:      
Proceeds from revolving loans 685,800,000 998,200,000 937,400,000
Repayment of revolving loans (795,300,000) (527,700,000) (928,400,000)
Proceeds from term loans 250,000,000 0 0
Repayment of long-term debt (19,832,000) (1,900,000) (1,900,000)
Payment of financing costs (586,000) 0 (3,796,000)
Proceeds from share issuances under share-based compensation plans 5,066,000 5,956,000 5,205,000
Payments for repurchases of common stock (18,365,000) (188,204,000) (203,294,000)
Net cash provided (used) by financing activities 106,783,000 286,352,000 (194,785,000)
Net cash provided (used) by financing activities (4,308,000) (11,739,000) 20,653,000
Cash and cash equivalents, beginning balance 33,381,000 45,120,000 24,467,000
Cash and cash equivalents, ending balance 29,073,000 33,381,000 45,120,000
Supplemental cash flow information:      
Interest paid 43,687,000 11,694,000 11,640,000
Income taxes paid, net of refunds 37,082,000 22,831,000 19,692,000
Supplemental non-cash investing activity:      
Capital expenditures included in accounts payable $ 5,847,000 $ 6,858,000 $ 0